B&L’s MoistureLoc Worldwide Recall: Firm Ties Formulation To Infection
This article was originally published in The Gray Sheet
Executive Summary
With evidence pointing to the basic formulation of Bausch & Lomb's ReNu with MoistureLoc contact lens solution as a contributing factor in an outbreak of serious eye infections, the company bit the bullet May 15 and issued a permanent, worldwide recall of the lucrative product
You may also be interested in...
FDA Is Revising Contact-Lens Guidelines To Protect Against Infections
The agency’s ophthalmic device advisory panel is meeting in May to address FDA’s plans to revise guidance documents describing 510(k) submissions for contact lenses and lens care products. The changes would incorporate lessons learned since the infectious outbreaks linked to multipurpose contact lens solution in the past decade.
AMO Lens Solution Recall Will Cut Sales By Up To $120 Million In 2007
The fallout from Advanced Medical Optics' May recall of its Complete MoisturePlus multipurpose contact lens solution will include lost sales of $100 million to $120 million this year, the firm projects
AMO Lens Solution Recall Will Cut Sales By Up To $120 Million In 2007
The fallout from Advanced Medical Optics' May recall of its Complete MoisturePlus multipurpose contact lens solution will include lost sales of $100 million to $120 million this year, the firm projects